Metformin and the risk of endometrial cancer: A case-control analysis

Gynecologic Oncology

Volumn 129, Issue 3, 2013, Pages 565-569

  Becker, Claudia ^a   Jick, Susan S ^b   Meier, Christoph R ^a,b,c   Bodmer, Michael ^a,d  

^a UNIVERSITY OF BASEL   (Switzerland)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d Spital Limmattal   (Switzerland)

Author keywords

Antidiabetic drugs; Diabetes mellitus; Endometrial cancer; Insulin; Metformin

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; INSULIN; METFORMIN; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ARTICLE; BODY MASS; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE DURATION; ENDOMETRIUM CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; ENDOMETRIAL NEOPLASMS; FEMALE; GENERAL PRACTICE; GREAT BRITAIN; HUMANS; HYPOGLYCEMIC AGENTS; INCIDENCE; LOGISTIC MODELS; METFORMIN; MIDDLE AGED;

EID: 84877576018     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.03.009     Document Type: Article

References (43)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J. Clin. 61 2011 69 90
2. D.C. Smith, R. Prentice, D.J. Thompson, and W.L. Herrmann Association of exogenous estrogen and endometrial carcinoma N. Engl. J. Med. 293 1975 1164 1167
3. A.G. Renehan, M. Tyson, M. Egger, R.F. Heller, and M. Zwahlen Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies Lancet 371 2008 569 578
4. S.C. Moore, G.L. Gierach, A. Schatzkin, and C.E. Matthews Physical activity, sedentary behaviours, and the prevention of endometrial cancer Br. J. Cancer 103 2010 933 938
5. E. Friberg, C.S. Mantzoros, and A. Wolk Physical activity and risk of endometrial cancer: a population-based prospective cohort study Cancer Epidemiol. Biomarkers Prev. 15 2006 2136 2140
6. D. Thompson, and D.F. Easton Cancer Incidence in BRCA1 mutation carriers J. Natl. Cancer Inst. 94 2002 1358 1365
7. C.P. McPherson, T.A. Sellers, J.D. Potter, R.M. Bostick, and A.R. Folsom Reproductive factors and risk of endometrial cancer. The Iowa Women's Health Study Am. J. Epidemiol. 143 1996 1195 1202
8. E. Friberg, N. Orsini, C.S. Mantzoros, and A. Wolk Diabetes mellitus and risk of endometrial cancer: a meta-analysis Diabetologia 50 2007 1365 1374
9. E. Weiderpass, I. Persson, H.O. Adami, C. Magnusson, A. Lindgren, and J.A. Baron Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden) Cancer Causes Control 11 2000 185 192
10. A.O. Mueck, H. Seeger, and T. Rabe Hormonal contraception and risk of endometrial cancer: a systematic review Endocr. Relat. Cancer 17 2010 R263 R271
11. C.M. Friedenreich, L.S. Cook, A.M. Magliocco, M.A. Duggan, and K.S. Courneya Case-control study of lifetime total physical activity and endometrial cancer risk Cancer Causes Control 21 2010 1105 1116
12. V.W. Setiawan, M.C. Pike, S. Karageorgi, S.L. Deming, K. Anderson, and L. Bernstein Age at last birth in relation to risk of endometrial cancer: pooled analysis in the epidemiology of endometrial cancer consortium Am. J. Epidemiol. 176 2012 269 278
13. A. Loerbroks, L.J. Schouten, R.A. Goldbohm, and P.A. van den Brandt Alcohol consumption, cigarette smoking, and endometrial cancer risk: results from The Netherlands Cohort Study Cancer Causes Control 18 2007 551 560
14. F. Bravi, L. Scotti, C. Bosetti, S. Gallus, E. Negri, and C. La Vecchia Coffee drinking and endometrial cancer risk: a meta-analysis of observational studies Am. J. Obstet. Gynecol. 200 2009 130 135
15. N. Mu, Y. Zhu, Y. Wang, H. Zhang, and F. Xue Insulin resistance: a significant risk factor of endometrial cancer Gynecol. Oncol. 125 2012 751 757
16. R.J. Shaw, K.A. Lamia, D. Vasquez, S.H. Koo, N. Bardeesy, and R.A. Depinho The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin Science 310 2005 1642 1646
17. M. Zakikhani, R. Dowling, I.G. Fantus, N. Sonenberg, and M. Pollak Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells Cancer Res. 66 2006 10269 10273
18. M. Zakikhani, R.J. Dowling, N. Sonenberg, and M.N. Pollak The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase Cancer Prev. Res. (Phila.) 1 2008 369 375
19. L.A. Cantrell, C. Zhou, A. Mendivil, K.M. Malloy, P.A. Gehrig, and V.L. Bae-Jump Metformin is a potent inhibitor of endometrial cancer cell proliferation - implications for a novel treatment strategy Gynecol. Oncol. 116 2010 92 98
20. Y. Xie, Y.L. Wang, L. Yu, Q. Hu, L. Ji, and Y. Zhang Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells J. Steroid Biochem. Mol. Biol. 126 2011 113 120
21. Z. Zhang, L. Dong, L. Sui, Y. Yang, X. Liu, and Y. Yu Metformin reverses progestin resistance in endometrial cancer cells by downregulating GloI expression Int. J. Gynecol. Cancer 21 2011 213 221
22. L. Dong, Q. Zhou, Z. Zhang, Y. Zhu, T. Duan, and Y. Feng Metformin sensitizes endometrial cancer cells to chemotherapy by repressing glyoxalase I expression J. Obstet. Gynaecol. Res. 38 2012 1077 1085
23. R.K. Hanna, C. Zhou, K.M. Malloy, L. Sun, Y. Zhong, and P.A. Gehrig Metformin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and modulation of the mTOR pathway Gynecol. Oncol. 125 2012 458 469
24. T. Walley, and A. Mantgani The UK General Practice Research Database Lancet 350 1997 1097 1099
25. L. Wood, and C. Martinez The General Practice Research Database: role in pharmacovigilance Drug Saf. 27 2004 871 881
26. S.S. Jick, J.A. Kaye, C. Vasilakis-Scaramozza, L.A. Garcia Rodriguez, A. Ruigomez, and C.R. Meier Validity of the general practice research database Pharmacotherapy 23 2003 686 689
27. R. Lawrenson, T. Williams, and R. Farmer Clinical information for research; the use of general practice databases J. Public Health Med. 21 1999 299 304
28. N.F. Khan, S.E. Harrison, and P.W. Rose Validity of diagnostic coding within the General Practice Research Database: a systematic review Br. J. Gen. Pract. 60 2010 e128 e136
29. E. Herrett, S.L. Thomas, W.M. Schoonen, L. Smeeth, and A.J. Hall Validation and validity of diagnoses in the General Practice Research Database: a systematic review Br. J. Clin. Pharmacol. 69 2010 4 14
30. Y.B. Brauchli, S.S. Jick, F. Curtin, and C.R. Meier Association between use of thiazolidinediones or other oral antidiabetics and psoriasis: a population based case-control study J. Am. Acad. Dermatol. 58 2008 421 429
31. C. Meier, M.E. Kraenzlin, M. Bodmer, S.S. Jick, H. Jick, and C.R. Meier Use of thiazolidinediones and fracture risk Arch. Intern. Med. 168 2008 820 825
32. M. Bodmer, C. Meier, S. Krahenbuhl, S.S. Jick, and C.R. Meier Long-term metformin use is associated with decreased risk of breast cancer Diabetes Care 33 2010 1304 1308
33. L. Azoulay, S. Dell'aniello, B. Gagnon, M. Pollak, and S. Suissa Metformin and the incidence of prostate cancer in patients with type 2 diabetes Cancer Epidemiol. Biomarkers Prev. 20 2011 337 344
34. M. Bodmer, C. Becker, C. Meier, S.S. Jick, and C.R. Meier Use of metformin and the risk of ovarian cancer: a case-control analysis Gynecol. Oncol. 123 2011 200 204
35. M. Bodmer, C. Becker, C. Meier, S.S. Jick, and C.R. Meier Use of metformin is not associated with a decreased risk of colorectal cancer: a case-control analysis Cancer Epidemiol. Biomarkers Prev. 212 2012 280 286
36. J.A. Johnson, S.L. Bowker, K. Richardson, and C.A. Marra Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias Diabetologia 54 2011 2263 2271
37. M. Lambe, A. Wigertz, H. Garmo, G. Walldius, I. Jungner, and N. Hammar Impaired glucose metabolism and diabetes and the risk of breast, endometrial, and ovarian cancer Cancer Causes Control 22 2010 1163 1171
38. E. Friberg, C.S. Mantzoros, and A. Wolk Diabetes and risk of endometrial cancer: a population-based prospective cohort study Cancer Epidemiol. Biomarkers Prev. 16 2007 276 280
39. K. Lindemann, L.J. Vatten, M. Ellstrom-Engh, and A. Eskild Body mass, diabetes and smoking, and endometrial cancer risk: a follow-up study Br. J. Cancer 98 2008 1582 1585
40. Z. Haoula, M. Salman, and W. Atiomo Evaluating the association between endometrial cancer and polycystic ovary syndrome Hum. Reprod. 27 2012 1327 1331
41. E. Weiderpass, W. Ye, H. Vainio, R. Kaaks, and H.O. Adami Diabetes mellitus and ovarian cancer (Sweden) Cancer Causes Control 13 2002 759 764
42. E. Lucenteforte, C. Bosetti, R. Talamini, M. Montella, A. Zucchetto, and C. Pelucchi Diabetes and endometrial cancer: effect modification by body weight, physical activity and hypertension Br. J. Cancer 97 2007 995 998
43. A.R. Tate, A. Nicholson, and J.A. Cassell Are GPs under-investigating older patients presenting with symptoms of ovarian cancer? Observational study using General Practice Research Database Br J Cancer 102 2010 947 951